Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2013-05-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore the objective is to examine the effect of an exercise-induced elevation of FFA on skeletal muscle lipid content in healthy lean men. To this end, skeletal muscle lipid content will be investigated at baseline and after an exercise protocol and again after a four-hour recovery period from exercise, once in a condition with high FFA concentration, once with low FFA concentration. To achieve high- versus low FFA concentrations, an exercise protocol was chosen and participants had to perform this protocol once with a glucose supplementation and once without.
Skeletal muscle lipid content will be determined before, directly after exercise and 4 h post exercise (from muscle biopsies) with or without glucose supplementation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elevated Circulating FFA and Intrahepatic Lipid Content
NCT01177332
Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation
NCT01494025
Body Composition and Lipid Metabolism at Rest and During Exercise: A Cross-Sectional Analysis.
NCT03029364
Familial Partial Lipodystrophy Study
NCT02858830
A Study of Adipose Tissue in Adaptive Responses to Exercise
NCT06053125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise & Glucose
2 hour exercise while getting glucose-supplementation
Exercise
Glucose
Exercise & Fasted
2 hour exercise while staying fasted
Exercise
Fasted
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Glucose
Fasted
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-30 years
* Lean, BMI 18-25 kg/m2
* Healthy
* Stable dietary habits
* No medication use
Exclusion Criteria
* Engagement in programmed exercise \> 2 hours total per week
* Cardiac problems, such as angina pectoris, cardiac infarction and arrhythmias
* First degree relatives with type 2 diabetes mellitus
* Any medical condition requiring treatment and/or medication use
* Unstable body weight (weight gain or loss \> 3 kg in the past three months)
* Participation in other biomedical study within 1 month prior to the screening visit
* Subjetcs, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed, cannot participate in the study
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lena Bilet
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Human Biology, Maastricht University Medical Center (MUMC)
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL43302.068.13/METC 13-3-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.